These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2782641)

  • 21. [Malignant hyperthermia: difficulty in diagnosing susceptibility in Spain].
    Montes A; Ramos R; Trillo L; Silva T; Puig MM
    Rev Esp Anestesiol Reanim; 1999 Mar; 46(3):130-2. PubMed ID: 10228380
    [No Abstract]   [Full Text] [Related]  

  • 22. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia.
    Isaacs H; Badenhorst M
    Anesthesiology; 1993 Jul; 79(1):5-9. PubMed ID: 8342829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined caffeine-halothane test for malignant hyperthermia.
    Nelson TE
    Br J Anaesth; 1993 May; 70(5):597-8. PubMed ID: 8318343
    [No Abstract]   [Full Text] [Related]  

  • 26. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
    Gallant EM; Fletcher TF; Goettl VM; Rempel WE
    Muscle Nerve; 1986 Feb; 9(2):174-84. PubMed ID: 3951491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Male preponderance of patients testing positive for malignant hyperthermia susceptibility.
    Islander G; Rydenfelt K; Ranklev E; Bodelsson M
    Acta Anaesthesiol Scand; 2007 May; 51(5):614-20. PubMed ID: 17430325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant hyperthermia of Duchenne muscular dystrophy: application of clinical grading scale and caffeine contracture of skinned muscle fibers].
    Takagi A
    Rinsho Shinkeigaku; 2000 May; 40(5):423-7. PubMed ID: 11002722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine malignant hyperthermia: false negatives in the halothane test.
    Gallant EM; Rempel WE
    Am J Vet Res; 1987 Mar; 48(3):488-91. PubMed ID: 3565905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malignant hyperthermia in Austria. II. A comparison of the results of diagnostic test procedures].
    Mauritz W; Hackl W; Sporn P; Graf M; Sluga E; Steinbereithner K
    Anaesthesist; 1988 Jul; 37(7):425-31. PubMed ID: 3414955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
    Flewellen EH; Nelson TE
    Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899
    [No Abstract]   [Full Text] [Related]  

  • 32. The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results.
    Brownell AK; Szabo M
    Can Anaesth Soc J; 1982 May; 29(3):218-21. PubMed ID: 7074401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of temperature, time and fascicle size on the caffeine contracture test.
    Britt BA; Endrenyi L; Scott E; Frodis W
    Can Anaesth Soc J; 1980 Jan; 27(1):1-11. PubMed ID: 7353184
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant hyperthermia--diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone.
    Wedel DJ; Nelson TE
    Anesth Analg; 1994 Apr; 78(4):787-92. PubMed ID: 8135402
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis of malignant hyperthermia: implications for the military.
    Biscardi HM; Muldoon SM; Condon BF
    Mil Med; 1985 Jun; 150(6):293-6. PubMed ID: 3927188
    [No Abstract]   [Full Text] [Related]  

  • 36. "Noninvasive" testing for malignant hyperthermia susceptibility.
    Allen PD; López JR
    Anesthesiology; 2002 Nov; 97(5):1045-6. PubMed ID: 12411783
    [No Abstract]   [Full Text] [Related]  

  • 37. The caffeine contracture test for malignant hyperthermia: caffeine citrate, caffeine benzoate or caffeine free base?
    Heytens L; Heffron JJ; Camu F
    Acta Anaesthesiol Scand; 1991 Aug; 35(6):541-4. PubMed ID: 1897351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing for malignant hyperthermia.
    Rosenberg H; Antognini JF; Muldoon S
    Anesthesiology; 2002 Jan; 96(1):232-7. PubMed ID: 11753023
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluoxetine treatment of a depressed patient susceptible to malignant hyperthermia.
    Burket RC; Hodgin JD
    Am J Psychiatry; 1989 May; 146(5):680. PubMed ID: 2785349
    [No Abstract]   [Full Text] [Related]  

  • 40. Regional lactate and carbon dioxide concentrations in a metabolic test for malignant hyperthermia.
    Anetseder M; Hager M; Müller-Reible C; Roewer N
    Lancet; 2003 Aug; 362(9382):494; discussion 494-5. PubMed ID: 12927444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.